+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

R

Actively Recruiting

This research aims to observe and evaluate the use of the SELUTION SLRTM sirolimus-coated balloon device in treating patients with coronary artery disease, including native vessel lesions and in-stent restenosis. It is a post-market, prospective, multicenter, international, observational study without a control group, focusing on real-world patients to assess the devices safety and effectiveness in everyday clinical practice. Participants receive treatment with the SELUTION SLRTM device as decided by their treating physician. The study monitors patients who have undergone this procedure in various clinical settings, including native coronary artery stenosis and coronary restenosis. This study does not include a comparator group and follows patients longitudinally after treatment. During participation, patients are followed up for at least 12 months to assess major adverse cardiovascular events, such as death, non-fatal heart attacks, and the need for further procedures on the treated lesions. Researchers evaluate both device-oriented and patient-oriented composite endpoints. The study collects data on treatment success shortly after the procedure and monitors safety and effectiveness outcomes over the year following treatment.

Age: 18Years +All Genders
16 locations